drugset / Trial / NCT06494774
A Study to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body of Healthy Japanese Men
RandomizedParallel-groupSingle-blindTreatment
Summary
The main objectives of this trial are to investigate safety, tolerability. pharmacokinetics (PK), and pharmacodynamics of BI 1815368 in healthy Japanese male subjects following administration of single rising doses or multiple doses.
Timeline
- Start
- 2024-08-19
- Primary completion
- 2024-11-13
- Completion
- 2024-11-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1815368 | Unknown | — | Oral |
Indications
No indication recorded.